AstraZeneca Will Pay Up to $6.9 Billion for Rights to Japanese Drugmaker’s Cancer Drug

AstraZeneca is aiming to expand its presence in the oncology industry with a new drug rights acquisition. The pharmaceutical company said on Thursday that it’s agreed to pay up to $6.9 billion for a cancer drug developed by Japanese drugmaker Daiichi-Sankyo. The sum includes an upfront payment of $1.4 billion and the possibility of paying […]